The global cell therapy market reached US$ 4.17 billion in 2023 and is expected to reach US$ 42.44 billion by 2031, growing at a CAGR of 30.67% during the forecast period 2024-2031.
Cell Therapy Market analysis, according to DataM Intelligence, offers more than just an overview, it investigates the underlying aspects of the sector. The study provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future.
Get a Free Sample PDF copy of the report - https://shorturl.at/JwCxG
The Cell Therapy market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.
Cell therapy involves the transplantation of cells into a patient to treat diseases or injuries. It includes therapies like stem cell therapy, where stem cells are used to repair damaged tissue. Cell therapy has shown promise in treating conditions such as cardiovascular diseases, autoimmune disorders, and neurodegenerative diseases. The therapy works by replacing damaged or diseased cells with healthy ones to restore function. Regulatory advancements are helping to make cell therapy more accessible to patients.
Forecast Growth Projected:
The Global Cell Therapy Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
List of the Key Players in the Cell Therapy Market:
Gilead Sciences, Inc., Novartis, AG, Vericel Corporation, CO.DON GmbH, Bristol Myers Squibb Company, IOVANCE Biotherapeutics, Inc., Dendreon Pharmaceuticals LLC, Enzyvant Therapeutics GmbH, CellTrans, Gamida Cell Inc.
Segment Covered in the Cell Therapy Market:
By Delivery Technology: Non Viral Delivery, Physical Methods, Chemical Methods, Viral Delivery.
By Cell Type: Stem Cell, Non-Stem Cell.
By Therapy Type: Autologous Therapy, Allogeneic Therapy.
By Application: Cancer, Autoimmune Disorders, Musculoskeletal Disorders, Dermatology, Others.
By End User: Hospitals, Specialty Clinics, Others.
Industry Development:
In August 2024, The Food and Drug Administration (FDA) has approved a cellular therapy known as afamitresgene autoleucel, or afami-cel (Tecelra), to treat individuals with metastatic synovial sarcoma, a type of soft tissue sarcoma. This is the first time the agency has approved a T-cell receptor (TCR) therapy for cancer.
Regional Break out:
The global Cell Therapy Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of Cell Therapy manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of Cell Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Frequently asked questions:
➠ What is the global sales value, production value, consumption value, import and export of Cell Therapy market?
➠ Who are the global key manufacturers of the Cell Therapy Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?
➠ What are the Cell Therapy market opportunities and threats faced by the vendors in the global Cell Therapy Industry?
➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?
➠ What focused approach and constraints are holding the Cell Therapy market?
➠ What are the different sales, marketing, and distribution channels in the global industry?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
